Press Releases and Statements
Your search for Press Release returned 1000 results.
MARCH 05, 2015
The Bill & Melinda Gates Foundation and CureVac Collaborate to Accelerate the Development of Transformative Vaccine Technology
SEATTLE, WA, USA and TÜBINGEN, GERMANY (March 5, 2015) – The Bill & Melinda Gates Foundation and CureVac today announced that the foundation has made a commitment to invest $52 million (€46 million) in CureVac, a leading clinical-stage biopharmaceutical company specializing in mRNA-based vaccine technologies. As part of the agreement, the foundation will also provide separate funding for several projects to develop prophylactic vaccines based on CureVac’s proprietary messenger RNA (mRNA) platform. In addition, CureVac’s longstanding investor dievini Hopp BioTech announced a commitment of $24 million (€21 million) of additional equity.
OCTOBER 14, 2014
Agence de Médecine Préventive Wins the 2014 Gates Vaccine Innovation Award for Improving Immunization Programs in Africa
PARIS (October 14, 2014) – The Bill & Melinda Gates Foundation today announced that Agence de Médecine Préventive (AMP) has received the third annual Gates Vaccine Innovation Award in recognition of EPIVAC, an on-the-job training program for district medical officers to improve immunization program performance in 11 Francophone African countries: Benin, Burkina Faso, Cameroon, Central African Republic, Côte d’Ivoire, Guinea, Mali, Mauritania, Niger, Senegal and Togo.